scispace - formally typeset
R

Raymond L. Erikson

Researcher at Harvard University

Publications -  140
Citations -  16619

Raymond L. Erikson is an academic researcher from Harvard University. The author has contributed to research in topics: Phosphorylation & MAP2K7. The author has an hindex of 63, co-authored 140 publications receiving 16198 citations. Previous affiliations of Raymond L. Erikson include Brigham Young University & Korea Research Institute of Bioscience and Biotechnology.

Papers
More filters
Journal ArticleDOI

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mrna splicing

TL;DR: A distinguishing feature of src-inducible prostaglandin synthase mRNA is its low abundance in nonproliferating chicken embryo fibroblasts and its relatively high abundance in src-transformed cells.
Journal ArticleDOI

Protein kinase activity associated with the avian sarcoma virus src gene product.

TL;DR: The expression of the protein kinase activity (ATP:protein phosphotransferase, EC 2.7.1.37) was growth temperature-dependent in cells infected with an ASV mutant temperature-sensitive for the transformation, and this activity was discussed in terms of protein phosphorylation as a mechanism for viral transformation.
Journal ArticleDOI

The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product

TL;DR: The structure of this protein kinase, denoted MEK1, was elucidated from a complementary DNA sequence and shown to be a protein of 393 amino acids that is related most closely in size and sequence to the product encoded by the Schizosaccharomyces pombe byr1 gene.
Journal ArticleDOI

Identification of a transformation-specific antigen induced by an avian sarcoma virus.

TL;DR: The identification of a 60,000-MW transformation-specific antigen detectable in ASV-transformed chicken cells andASV-induced hamster tumour cells is described by immunoprecipitation of radiolabelled cell extracts with serum from tumour-bearing rabbits.
Journal ArticleDOI

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

TL;DR: It is found that Plk1 depletion dramatically inhibited cell proliferation, decreased viability, and resulted in cell-cycle arrest with 4 N DNA content, which supports the notion that disruption of PlK1 function could be an important application in cancer therapy.